Clinical trials begin for COVID-19 oral therapeutics discove

According to a Friday morning news release from Louisiana State University (LSU), Skymount Medical has partnered with Riverside University Health System, or RUHS, Medical Center to conduct the first U.S. clinical trial on the efficacy of COVID-19 oral therapeutics discovered by LSU researchers using artificial intelligence, or AI.

Related Keywords

Moreno Valley , California , United States , Louisiana , Riverside , Baton Rouge , Supratik Mukhopadhyay , Riverside University Health System , Emergency Department , Division Of Computer Science , Louisiana State University , Illinois Institute Of Technology , Center Comparative Effectiveness Clinical Outcomes Research , Skymount Medical , Medical Center , Comparative Effectiveness , Clinical Outcomes Research Center , Illinois Institute , Computer Science , Covid , Lsu , Coronavirus , Drug Therapy ,